[
  {
    "ts": "2025-12-16T13:00:00+00:00",
    "headline": "Corteva, Hexagon Bio Form Multi-Million Dollar JV to Power Next-Generation of Nature Inspired Solutions",
    "summary": "INDIANAPOLIS & MENLO PARK, Calif., December 16, 2025--Corteva (NYSE: CTVA), a global leader in agricultural technology, and Hexagon Bio, a biotechnology company pioneering a new way to discover nature-derived medicine, today announced a multi-million-dollar joint venture (JV) to accelerate the development of new crop protection solutions inspired by nature. The JV is the first in the agriculture sector for Hexagon Bio and the first in the pharmaceutical industry for Corteva.",
    "url": "https://finance.yahoo.com/news/corteva-hexagon-bio-form-multi-130000441.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "a0953054-0bcc-3b69-9063-f44522211747",
      "content": {
        "id": "a0953054-0bcc-3b69-9063-f44522211747",
        "contentType": "STORY",
        "title": "Corteva, Hexagon Bio Form Multi-Million Dollar JV to Power Next-Generation of Nature Inspired Solutions",
        "description": "",
        "summary": "INDIANAPOLIS & MENLO PARK, Calif., December 16, 2025--Corteva (NYSE: CTVA), a global leader in agricultural technology, and Hexagon Bio, a biotechnology company pioneering a new way to discover nature-derived medicine, today announced a multi-million-dollar joint venture (JV) to accelerate the development of new crop protection solutions inspired by nature. The JV is the first in the agriculture sector for Hexagon Bio and the first in the pharmaceutical industry for Corteva.",
        "pubDate": "2025-12-16T13:00:00Z",
        "displayTime": "2025-12-16T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/2b30195470b88f6ddc4f2d829c90abfa",
          "originalWidth": 7649,
          "originalHeight": 1328,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PWMx3tJmOyzsuQquaOyyWQ--~B/aD0xMzI4O3c9NzY0OTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/business-wire.com/2b30195470b88f6ddc4f2d829c90abfa.cf.webp",
              "width": 7649,
              "height": 1328,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Le5gJs1aMtanj1B6Z1KQMA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/2b30195470b88f6ddc4f2d829c90abfa.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/corteva-hexagon-bio-form-multi-130000441.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/corteva-hexagon-bio-form-multi-130000441.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CTVA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]